KarloPericaMD

PubMed

• Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies.
  Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, Hongyao Xie, Nayan Jain, Taha Merghoub, Michel Sadelain, Mohamad Hamieh, Karlo Perica, Andrew Chow, Jedd D Wolchok> ;Nature Cancer. 2024 Mar 19
• 157 citations
  Clinical implications of T cell exhaustion for cancer immunotherapy.
  Andrew Chow, Karlo Perica, Christopher A Klebanoff, Jedd D Wolchok> ;Nature Reviews. Clinical Oncology. 2022 Dec 1
• 14 citations
  Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant.
  David J Chung, Sneh Sharma, Madhumitha Rangesa, Susan DeWolf, Yuval Elhanati, Karlo Perica, James W Young> ;Blood Advances. 2022 Mar 8
• 20 citations
  Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic L...
  Sanam Shahid, Kavitha Ramaswamy, Jessica Flynn, Audrey Mauguen, Karlo Perica, Jae H. Park, Christopher J. Forlenza, Peter G. Steinherz, Steven P. Margossian, Jaap Jan ...> ;Transplantation and Cellular Therapy. 2021 Nov 28
• 1 citations
  Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin
  Jung Seok Lee, Patrick Han, Rabib Chaudhury, Shihan N. Khan, Sean Bickerton, Michael D McHugh, Hyun Bong Park, Alyssa Siefert, Gerald Rea, José M. Carballido, David A....> ;Nature Biomedical Engineering. 2021 Nov 4
• 20 citations
  Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.
  Jung Seok Lee, Patrick Han, Rabib Chaudhury, Shihan N. Khan, Sean Bickerton, Michael D McHugh, Hyun Bong Park, Alyssa Siefert, Gerald Rea, José M. Carballido, David A....> ;Nature Biomedical Engineering. 2021 Sep 1
• 18 citations
  Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia.
  Karlo Perica, Jessica Flynn, Kevin J. Curran, Isabelle Rivere, Xiuyan Wang, Brigitte Senechal, Elizabeth Halton, Claudia Diamonte, John Pineda, Yvette Bernal, Mithat G...> ;Leukemia. 2021 Mar 8
• Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.
  Karlo Perica, M. Lia Palomba, Renier J. Brentjens> ;Advances in Cell and Gene Therapy. 2018 Oct 7
• 1 citations
  Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.
  Christian Schütz, Juan Carlos Varela, Karlo Perica, Carl Haupt, Mathias Oelke, Jonathan P. Schneck> ;Oncotarget. 2018 Aug 17
• 55 citations
  Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center.
  Karlo Perica, Kevin J. Curran, Renier J. Brentjens, Sergio Giralt> ;Biology of Blood and Marrow Transplantation. 2018 Jun 1
• 21 citations
  Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells
  Christian Schütz, Juan Carlos Varela, Karlo Perica, Carl Haupt, Mathias Oelke, Jonathan P. Schneck> ;Oncotarget. 2016 Sep 1
• 180 citations
  Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
  Yvette L. Kasamon, Javier Bolaños-Meade, Gabrielle T. Prince, Hua Ling Tsai, Shannon R. McCurdy, Jennifer A. Kanakry, Gary L. Rosner, Robert A. Brodsky, Karlo Perica, ...> ;Journal of Clinical Oncology. 2015 Aug 10
• 96 citations
  Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
  Karlo Perica, Joan G. Bieler, Christian Schütz, Juan Carlos Varela, Andrew D. Skora, Yen-Ling Chiu, Mathias Oelke, Kenneth W. Kinzler, Shibin Zhou, Bert Vogelstein, Jo...> ;ACS Nano. 2015 Jul 14
• 222 citations
  Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
  Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua Ling Tsai, Javier Bolaños-Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symo...> ;Blood. 2015 May 7
• 123 citations
  Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation
  Randall A. Meyer, Joel C. Sunshine, Karlo Perica, Alyssa K. Kosmides, Kent Aje, Jonathan P. Schneck, Jordan J. Green> ;Small. 2015 Apr 1
• 38 citations
  Linking form to function: Biophysical aspects of artificial antigen presenting cell design
  Karlo Perica, Alyssa K. Kosmides, Jonathan P. Schneck> ;Biochimica Et Biophysica Acta. 2015 Apr 1
• 124 citations
  Adoptive T cell immunotherapy for cancer.
  Karlo Perica, Juan Carlos Varela, Mathias Oelke, Jonathan P. Schneck> ;Rambam Maimonides Medical Journal. 2015 Jan 29
• Magnetic field-induced receptor clustering by nanoparticles stimulates anti-tumor activity in vivo.
  Perica, K.,Schneck, J.> ;J Altern Complement Med. 2014 May 09
• 143 citations
  Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.
  Karlo Perica, Ang A. Tu, Anne Richter, Joan G. Bieler, Michael Edidin, Jonathan P. Schneck> ;ACS Nano. 2014 Feb 24
• 92 citations
  Nanoscale artificial antigen presenting cells for T cell immunotherapy.
  Karlo Perica, Andrés De León Medero, Malarvizhi Durai, Yen-Ling Chiu, Joan Glick Bieler, Leah V. Sibener, Michaela Niemöller, Mario Assenmacher, Anne Richter, Michael ...> ;Nanomedicine. 2014 Jan 1
• 173 citations
  Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
  Joel C. Sunshine, Karlo Perica, Jonathan P. Schneck, Jordan J. Green> ;Biomaterials. 2014 Jan 1
• 8 citations
  Modulation of MHC binding by lateral association of TCR and coreceptor.
  Karlo Perica, Joan Glick Bieler, Michael Edidin, Jonathan P. Schneck> ;Biophysical Journal. 2012 Nov 7
• 61 citations
  The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles.
  Robert M. Samstein, Karlo Perica, Fanor Balderrama, Michael Look, Tarek M. Fahmy> ;Biomaterials. 2008 Feb 1
• Join now to see all

Lectures

• Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL. 
  2019 ASCO Annual Meeting - 6/1/2019